In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing for a healthcare partner in Puerto Rico. By the end of November, CTS implements universal individual Zika testing on all blood donations in the US, due to an FDA requirement.
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...